A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China

NCT03235778 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Felbinac Trometamol Injection
DRUG: Placebo

Sponsor

Yiling Pharmaceutical Inc.